Podcast Center - Applied Clinical Trials

ADVERTISEMENT


Clinical Innovation Podcast
Thomas Krohn, Director of Clinical Open Innovation, a transformation initiative in the Lilly Research Labs R&D department, discusses Patient Centricity in this podcast.
Cenduit Quickcast - Improving Patient Compliance
Host Lex Raleigh talks with Mark Taggart about challenges site staff face and solutions to decrease recruitment costs and increase patient retention, adherence, and compliance.
Challenges in Oncology Trials in Ontario
Karen Arts, is the Director of Business Development, High Impact Clinical Trials Program at the Ontario Institute for Cancer Research in Toronto, Canada discusses challenges in oncology trials in Ontario with Roberto Lara, Director of Business Development for Scimega Research.
How Effective Resource Planning Reduces Study Cost and Risk
Join Lisa Henderson, Editor in Chief of Applied Clinical Trials, and Molly Blake-Michaels, Senior Director, Clinical Services at ClearTrial, as they discuss how leading sponsors are significantly improving their resource planning for clinical studies.
Making Preferred Provider Relationships Work
Join Lisa Henderson, Editor in Chief of Applied Clinical Trials, and Mindy Davis, Senior Director, Clinical Services at ClearTrial, as they discuss the challenges and benefits of preferred provider relationships being formed between study sponsors and their CRO partners.
How to Avoid 5 Common Project Management Mistakes in Clinical Trials
Join Lisa Henderson, Editor in Chief of Applied Clinical Trials, and Rachel Yagur, Manager, Clinical Services at ClearTrial, as they discuss how leading sponsors are applying best practices in planning and communication to avoid common project management mistakes in clinical trials.
Montrium CEO Paul Fenton Discusses the Need for Electronic Document Workflow
Paul Fenton, President and CEO of Montrium, on how electronic workflow changes business process and brings efficiencies to eTMP, eCTD, and overall document awareness.
Greenphire CEO Sam Whitaker Discusses the Financial Pain Points for the Investigative Site, and How to Solve Them
Sam Whitaker, CEO of Greenphire, discusses the company’s success to date with its financial payments technology, global capabilities for next year, and how financial pressures are changing trials for the better.
Parexel's Ethnobridging Expert Discusses Its Importance as a Development Strategy
Stan Jhee, PharmD, Senior Director of Research, Early Phase at Parexel, defines the importance of ethnobridging in clinical trials, and how it works as a drug development strategy for pharmaceutical companies.
CER and Personalized Medicine: Insights from the Experts
Kathy Wyrwich, Senior Research Leader, Outcomes Research, United BioSource, shares insights on comparative effectiveness research and personalized medicine with discussions she had with stakeholders from Pfizer, Duke University School of Medicine and Medco Research Institute.
eClinical Software Trends, part 2
Part 2 from Alan Louie, PhD, Research Director, Health Industry Insights.
eClinical Software Trends, part 1
Alan Louie, PhD, Research Director, Health Industry Insights, provides an update of the eClinical market, where the growth is, and the complexity in the ecosystem.
INC's CEO Discusses the Current CEO Climate
Jim Ogle, CEO of INC Research, offers his take on industry consolidation, what it means for the future, and INC’s own role and strategy in its recent acquisitions.
Shire's Move from R&D to Search and Development: An IT Perspective, Part II
In part 2, Charlie Dougherty, Director of R&D IT for Shire Specialty Pharmaceuticals, discusses technology changes in the next five years and how Shire is leveraging externally hosted environments and the cloud to address its search and development strategy.
Shire's Move from R&D to Search and Development: An IT Perspective, Part I
Charlie Dougherty, Director of R&D IT for Shire Specialty Pharmaceuticals, discusses leveraging externally hosted environments and the cloud to address the pharma R&D group of the future.
The Business Behind Clinical Trials
Paula Brown Stafford, President of Quintiles Clinical Development shares her thoughts on clinical trial management.
Web Solutions Can Improve Document Exchange
Linda Bowers, Vice President Life Sciences Product Marketing for IntraLinks, discusses study start-up bottlenecks and how they can be addressed by sponsors using technology to move beyond paper trails..
Applying the Principles of Lean Process Improvement to More Effectively Manage Study Close-out Inventories
Sponsored by Aptuit
Esther Sadler-Williams and Kenneth Strømdahl discuss how the principles of lean process were applied to improve management of inventory closeouts that occur at the end of clinical trials.
Getting Data with Benefits
Roy Devine, Associate Vice President Life Sciences Applications and solutions for iGate Patni, discusses data with benefits: repositories and future integration.
UBC's Adam Butler Discusses Its New eClinical Company
UBC combines pre-existing clinical technologies and clinical services groups to form new entity, bracket.
Constructing Price Indexes for Clinical Trials
Iain Cockburn and Lori Shields discuss how Medidata's proprietary databases determine accurate cost components for clinical trials.
Comprehend Systems' Discusses New Analytic Offering
The CEO of Comprehend Systems shares details about the second version of their analytics software tool.
INC Research Discusses How CROs Can Help Oncology Trials
Dr. Mike Kurman talks about the barriers to oncology drug development.
Web Portals, Dashboards, and Technology Trends from Health Decisions' CEO
Web portals and other tech trends for clinical research.
Global Regulatory Capacity
DIA’s Paul Pomerantz discusses challenges and solutions to global regulatory capacity.
Preparing for Future Trends in Risk Management
Sponsored by REGISTRAT-MAPI
Dr William C. Maier, REGISTRAT-MAPI, on incorporating new strategies and trends in risk management.
FDAs New Ground on Medication Guides in REMs, What it Means: A UBC Perspective
Discover what FDA’s new guidance on Medication Guides really means to sponsors and REMS.
Preparing for Future Trends in Risk Management
Sponsored by REGISTRAT-MAPI
Dr William C. Maier, REGISTRAT-MAPI, on incorporating new strategies and trends in risk management.
Merck’s Biosimilars Business, From Parexel’s Perspective
Chairman and CEO of Parexel shares how the CRO won Merck's business.
Trial Budget Clarity
A conversation with ClearTrial about budget tolerance and its product suite.
Get Meaning From Your Data
Exectuvies at Patni Life Sciences share their insights on predictive analytics.
Build a Drug's Value in Early
A look at UBC's acquisition of Total Healthcare Group and the impact of comparative effectiveness research.
Biosimilars in the US
An overview of the FDA meeting disucssing regulations for the approval of generic versions of biological products.
Proven Methods for Reducing Change Orders and Assessing Their Impact
Sponsored by CleartTrial
Listen to how forward-thinking biopharmaceutical and medical device companies are reducing change orders during clinical trials – and how they are managing change orders more effectively when they do occur.
46th DIA Annual Meeting Preview
A sneak peek of what speaker's at DIA's 46th Annual Meeting will be talking about at the conference this year.
Diabetes & Obesity Series
In this series, we explore the expanded health issue of metabolic syndrome, which comprises diabetes, obesity and lipid disorders.
45th DIA Annual Meeting
Behind the scenes of DIA's 45th Annual Meeting, Applied Clinical Trials speaks with presenters about the topics they are discussing at the conference.
Global Trial Considerations
Sponsored by MDS Pharma Services
From project management, to regulatory concerns, to specific challenges with emerging markets, learn more about conducting global clinical trials.
Ins and Outs of Comparator Sourcing
Sponsored by IDIS
Learn more about sourcing strategies for drugs in clinical trials and how it can be achieved more effectively and strategically.
eCTD: Learn from Early Adopters
Implementation of the electronic Common Technical Document or eCTD is still early on the adoption curve within the pharmaceutical industry. Regulatory professionals will be interested to hear the insights from participants of an eCTD Early Adopters Roundtable sponsored by Applied Clinical Trials and Clarkston Consulting.
Early Phase Patient Studies
Join Lisa Henderson, Editor in Chief of Applied Clinical Trials, and Gerd Arold, MD, Senior Director Scientific Affairs, Patient Pharmacology, Early Development Services at PRA, as they discuss Early Development Services, and market requirements for Early Phase Patient Studies.

ADVERTISEMENT

ADVERTISEMENT

Untitled Document

Click here